A perennial focus of regulators, health care fraud enforcement remained active in 2021 and is expected to continue in the year ahead. Below we look at some of the drivers of that enforcement activity. Our key takeaways:
- Opioid enforcement actions will remain extremely active in the coming year, including with respect to doctors and pharmacists, not just health care companies and their executives.
- Pandemic-related fraud will continue to be a priority of federal and state enforcement agencies, including investigation regarding the use of pandemic relief funds, fraudulent testing schemes, and false vaccine documentation.
- As the evolving state of the COVID-19 pandemic brings new health services to more Americans, telehealth in particular will be a focus.
- Enforcement agencies will be especially attentive to any actions taken against vulnerable populations, including older adults and recipients of home health services.
Source:
- Foley Hoag via JD Supra: Health Care Enforcement – A Look Ahead
